BeyondSpring Inc. (NASDAQ:BYSI – Get Free Report) shares crossed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $1.67 and traded as low as $1.34. BeyondSpring shares last traded at $1.34, with a volume of 45,205 shares.
BeyondSpring Trading Down 10.7 %
The firm’s fifty day simple moving average is $1.67 and its 200-day simple moving average is $1.84.
About BeyondSpring
BeyondSpring Inc, a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia.
Featured Articles
- Five stocks we like better than BeyondSpring
- How to invest in marijuana stocks in 7 steps
- Newsmax’s IPO Whiplash: Meme Stock Hype or Growth Potential?
- What Are Earnings Reports?
- Disney 2025 Shareholders: Major Updates for Investors
- How to Read Stock Charts for Beginners
- Advance Auto Parts Stock: A Classic Rebound Play in the Making
Receive News & Ratings for BeyondSpring Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BeyondSpring and related companies with MarketBeat.com's FREE daily email newsletter.
